Skip to content

4Accepted Oct 2, 4:40 PM ET

Versant Venture Capital VI, L.P. 4

LENZLENZ Therapeutics, Inc.

sec.gov(opens the filing on sec.gov)View full filing

Accepted (ET)

4:40 PM

Oct 2, 2025

Filed

Oct 2, 2025

Documents

1

Size

30.6 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.